NYU Grossman School of Medicine
Daniel H. Sterman, M.D., is the Thomas and Suzanne Murphy Professor of Pulmonary, Critical Care Medicine in the Departments of Medicine and Cardiothoracic Surgery at the New York University Grossman School of Medicine, Director of the Division of Pulmonary, Critical Care, and Sleep Medicine, and Director of the Multidisciplinary Pulmonary Oncology Program at NYU Langone Health in NYc. He lead clinical investigator multidisciplinary Thoracic Oncology Research Group at the Perelman School of Medicine at the University of Pennsylvania and the Principal Investigator of the Clinical Trials Project for Penn NCI thoracic oncology program project grant from 1997-2015.
Dr. Sermans research interest are the treatment of thoracic malignancies, in relation to the synergy of molecular medicine, tumor immunotherapy and novel technologies in Interventional Pulmonology. Over the past 25 years, he has focused on the translation of laboratory discoveries from bench to the bedside: conducting multiple human clinical trials of gene therapy and vaccine therapy for lung cancer, mesothelioma, and other pleural malignancies.
As Director of the NYU PORT (Pulmonary Oncology Research Team), he has expanded his research interests into assessment of the immune microenviroment of tumor-draining lymph nodes, and development of local intra-tumoral and intra-nodal immunotherapies. He is co-national PI of the LuTK02 clinical trial of intratumoral CAN-2409 in patients with advanced non-small cell lung cancer refractory to immune checkpoint inhibition, and global PI of the INFINITE clinical trial, a randomized Phase III clinical trial of intrapleural adenovirus-interferon alpha 2b with chemotherapy as second/third line therapy for unresectable malignant pleural mesothelioma.
Disclosure information not submitted.
Wednesday, August 24, 2022
8:55 AM – 10:45 AM
Wednesday, August 24, 2022
9:00 AM – 9:20 AM
Wednesday, August 24, 2022
10:25 AM – 10:45 AM